References
- Mathew J, Kratzke RA. Lung cancer and lung transplantation: a review. J Thorac Oncol 2009; 4: 753-60. doi: 10.1097/JTO.0b013e31819afdd9
- Choi YH, Leung AN, Miro S, Poirier C, Hunt S, Theodore J. Primary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findings. J Thorac Imaging 2000; 15: 36-40.
- Raviv Y, Shitrit D, Amital A, Fox B, Rosengarten D, Fruchter O, et al. Lung cancer in lung transplant recipients: experience of a tertiary hospital and literature review. Lung Cancer 2011; 74: 280-3. doi: 10.1016/j.lungcan.2011.02.012
- Du L, Pennell NA, Elson P, Hashemi-Sadraei N. Lung cancer treatment outcomes in recipients of lung transplant. Transl Lung Cancer Res 2015; 4: 784-91. doi: 10.3978/j.issn.2218-6751.2015.12.08
- Collins J, Kazerooni EA, Lacomis J, McAdams HP, Leung AN, Shiau M, et al. Bronchogenic carcinoma after lung transplantation: frequency, clinical characteristics, and imaging findings. Radiology 2002; 224: 131-8. doi: 10.1148/ radiol.2241011189
- Dickson RP, Davis RD, Rea JB, Palmer SM. High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant 2006; 25: 1297-301. doi: 10.1016/j.healun.2006.09.009
- Timmerman RD, Hu C, Michalski J, Straube W, Galvin J, Johnstone D, et al. Long-term results of RTOG 0236: a phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2014; 90: S30. doi: 10.1016/j.ijrobp.2014.05.135
- Fitton TP, Bethea BT, Borja MC, Yuh DD, Yang SC, Orens JB, et al. Pulmonary resection following lung transplantation. Ann Thorac Surg 2003; 76: 1680-6. doi: 10.1016/s0003-4975(03)00975-5
- Nyman J, Hallqvist A, Lund J-A, Brustugun OT, Bergman B, Bergström P, et al. SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother Oncol 2016; 121: 1-8. doi: 10.1016/j.radonc.2016.08.015
- Ball D, Mai GT, Vinod S, Babington S4, Ruben J5, Kron T, et al. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol 2019; 20: 494-503. doi: 10.1016/S1470-2045(18)30896-9
- Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015; 16: 630-7. doi: 10.1016/S1470-2045(15)70168-3
- Zheng X, Schipper M, Kidwell K, Lin J, Reddy R, Ren Y, et al. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys 2014; 90: 60311. doi: 10.1016/j.ijrobp.2014.05.055
- Ros J, Matos I, Martin-Liberal J. Immunotherapy in organ-transplanted cancer patients: efficacy and risk of organ rejection. Ann Oncol 2019; 30: 1173-7. doi: 10.1093/annonc/mdz129
- Walle T, Martinez Monge R, Cerwenka A, Ajona D, Melero I, Lecanda F. Radiation effects on antitumor immune responses: current perspectives and challenges. Ther Adv Med Oncol 2018; 10: 1758834017742575. doi: 10.1177/1758834017742575
- Fleming CW, Stephans KL, Broughman JR, Rybicki L, Budev M, Ahmad U, et al. Outcomes after SBRT for inoperable early stage lung cancers arising in organ transplant patients. Int J Radiat Oncol Biol Phys 2019; 105: E486. doi: 10.1016/j.ijrobp.2019.06.1382
- Chen H, Tikkanen J, Boldt RG, Louie A V. Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation. Radiat Oncol 2018; 13: 142. doi: 10.1186/s13014-018-1089-8